Role of linc01410 in the occurrence and development of malignant tumors

Abstract

Liu Yang, Jiang Lulu, Guan Kaiwen, Zhou Yueyang, Kang Xiaohong. Role of linc01410 in the occurrence and development of malignant tumors[J]. Journal of International Oncology, 2023, 50(9): 540-543.

References32

[1]	Liu R, Liu Q. Multivariate saturation treatment of malignant tumor[J].Asian J Surg,2021,44(1): 1. DOI:10.1016/j.asjsur.2020.10.023. pmid:33221133
[2]	Zeng Y, Yu D, Tian W, et al. Resistance mechanisms to osimertinib and emerging therapeutic strategies in nonsmall cell lung cancer[J].Curr Opin Oncol,2022,34(1): 54-65. DOI:10.1097/CCO.0000000000000805.
[3]	Bridges MC, Daulagala AC, Kourtidis A. LNCcation: lncRNA locali-zation and function[J].J Cell Biol,2021,220(2): e202009045. DOI:10.1083/jcb.202009045.
[4]	Xing C, Sun SG, Yue ZQ, et al. Role of lncRNA LUCAT1 in cancer[J].Biomed Pharmacother,2021,134: 111158. DOI:10.1016/j.biopha.2020.111158. pmid:33360049
[5]	Li YH, Hu YQ, Wang SC, et al. LncRNA SNHG5: a new budding star in human cancers[J].Gene,2020,749: 144724. DOI:10.1016/j.gene.2020.144724.
[6]	Luo J, Guo Y, Liu X, et al. Long non-coding RNA LINC01410 promotes colon cancer cell proliferation and invasion by inhibiting miR-3128[J].Exp Ther Med,2018,16(6): 4824-4830. DOI:10.3892/etm.2018.6806. pmid:30546401
[7]	Roviello G, Petrioli R, Marano L, et al. Angiogenesis inhibitors in gastric and gastroesophageal junction cancer[J].Gastric Cancer,2016,19(1): 31-41. DOI:10.1007/s10120-015-0537-5. pmid:26329368
[8]	Zhao X, Shen F, Yang B. LncRNA LINC01410 induced by MYC accelerates glioma progression via sponging miR-506-3p and modulating NOTCH2 expression to motivate notch signaling pathway[J].Cell Mol Neurobiol,2022,42(5): 1513-1521. DOI:10.1007/s10571-021-01042-1.
[9]	王海波, 刘欢, 刘宽. lncRNA LINC01410通过miR-205-5p调控胶质瘤A172细胞的增殖、凋亡和替莫唑胺敏感性[J].中国肿瘤生物治疗杂志,2021,28(9): 908-913. DOI:10.3872/j.issn.1007-385x.2021.09.007.
[10]	Dongre A, Weinberg RA. New insights into the mechanisms of epithelial-mesenchymal transition and implications for cancer[J].Nat Rev Mol Cell Biol,2019,20(2): 69-84. DOI:10.1038/s41580-018-0080-4.
[11]	Guo W, Gai Q, Ma Y, et al. LINC01410 leads the migration, invasion and EMT of bladder cancer cells by modulating miR-4319/Snail1[J].Cancer Cell Int,2021,21(1): 429. DOI:10.1186/s12935-021-02119-z.
[12]	Altorki NK, Markowitz GJ, Gao D, et al. The lung microenvironment: an important regulator of tumour growth and metastasis[J].Nat Rev Cancer,2019,19(1): 9-31. DOI:10.1038/s41568-018-0081-9. pmid:30532012
[13]	Zhang JX, Chen ZH, Chen DL, et al. LINC01410-miR-532-NCF2-NF-κB feedback loop promotes gastric cancer angiogenesis and metastasis[J].Oncogene,2018,37(20): 2660-2675. DOI:10.1038/s41388-018-0162-y.
[14]	蔡民, 许浏, 沈兰, 等. 胰腺癌组织中长链非编码RNA LINC01410的表达及其对胰腺癌细胞增殖和迁移的影响[J].中华医学杂志,2019,99(18): 1406-1411. DOI:10.3760/cma.j.issn.0376-2491.2019.18.010.
[15]	Jiang T, Wang C, Zhu Y, et al. LINC01410 promotes cell proli-feration and migration of cholangiocarcinoma through modulating miR-124-3p/SMAD5 axis[J].J Gene Med,2020,22(6): e3162. DOI:10.1002/jgm.3162.
[16]	Wang G, Wang X, Jin Y. LINC01410/miR-3619-5p/FOXM1 feedback loop regulates papillary thyroid carcinoma cell proliferation and apoptosis[J].Cancer Biother Radiopharm,2019,34(9): 572-580. DOI:10.1089/cbr.2019.2854.
[17]	Xu Q, He L, Ma L, et al. LINC01410 accelerated the invasion and proliferation of osteosarcoma by sponging miR-3128[J].Aging (Albany NY),2020,12(24): 24957-24966. DOI:10.18632/aging.103464.
[18]	Mi J, Han Y, Zhang J, et al. Long noncoding RNA LINC01410 promotes the tumorigenesis of neuroblastoma cells by sponging microRNA-506-3p and modulating WEE1[J].Cancer Med,2020,9(21): 8133-8143. DOI:10.1002/cam4.3398.
[19]	Conte F, Fiscon G, Sibilio P, et al. An overview of the computational models dealing with the regulatory ceRNA mechanism and ceRNA deregulation in cancer[J].Methods Mol Biol,2021,2324: 149-164. DOI:10.1007/978-1-0716-1503-4_10. pmid:34165714
[20]	Liu F, Wen C. LINC01410 knockdown suppresses cervical cancer growth and invasion via targeting miR-2467-3p/VOPP1 axis[J].Cancer Manag Res,2020,12: 855-861. DOI:10.2147/CMAR.S236832. pmid:32104067
[21]	Shang C, Li Y, He T, et al. The prognostic miR-532-5p-correlated ceRNA-mediated lipid droplet accumulation drives nodal metastasis of cervical cancer[J].J Adv Res,2022,37: 169-184. DOI:10.1016/j.jare.2021.09.009. pmid:35499057
[22]	薛华, 安宁, 向光明, 等. lncRNALINC01410靶向miR-205-5p抑制胰腺癌细胞放疗敏感性的研究[J].中国临床药理学杂志,2022,38(20): 2434-2439. DOI:10.13699/j.cnki.1001-6821.2022.20.011.
[23]	Ma W, Gao Y, Zhang J, et al. Long noncoding RNA LINC01410 promotes tumorigenesis of osteosarcoma cells via miR-497-5p/HMGA2 axis[J].J Biochem Mol Toxicol,2021,35(12): e22921. DOI:10.1002/jbt.22921.
[24]	Lu M, Ding N, Zhuang S, et al. LINC01410/miR-23c/CHD7 functions as a ceRNA network to affect the prognosis of patients with endometrial cancer and strengthen the malignant properties of endometrial cancer cells[J].Mol Cell Biochem,2020,469(1/2): 9-19. DOI:10.1007/s11010-020-03723-9.
[25]	Taniguchi K, Karin M. NF-κB, inflammation, immunity and cancer: coming of age[J].Nat Rev Immunol,2018,18(5): 309-324. DOI:10.1038/nri.2017.142. pmid:29379212
[26]	Peng C, Ouyang Y, Lu N, et al. The NF-κB signaling pathway, the microbiota, and gastrointestinal tumorigenesis: recent advances[J].Front Immunol,2020,11: 1387. DOI:10.3389/fimmu.2020.01387. pmid:32695120
[27]	Lu L, Zhang S, Song Z, et al. Long non-coding RNA LINC01410 promoted tumor progression via the ErbB signaling pathway by targeting STAT5 in gallbladder cancer[J].Front Oncol,2021,11: 659123. DOI:10.3389/fonc.2021.659123.
[28]	Schulze WX, Deng L, Mann M. Phosphotyrosine interactome of the ErbB-receptor kinase family[J].Mol Syst Biol,2005,1: 2005. 0008. DOI:10.1038/msb4100012.
[29]	Fu T, Yang Y, Mu Z, et al. Silencing lncRNA LINC01410 suppresses cell viability yet promotes apoptosis and sensitivity to temozolomide in glioblastoma cells by inactivating PTEN/AKT pathway via targeting miR-370-3p[J].Immunopharmacol Immunotoxicol,2021,43(6): 680-692. DOI:10.1080/08923973.2021.1966031.
[30]	Zhang W, Wang Q, Yang Y, et al. The role of exosomal lncRNAs in cancer biology and clinical management[J].Exp Mol Med,2021,53(11): 1669-1673. DOI:10.1038/s12276-021-00699-4. pmid:34819615
[31]	Chen X, Song E. Turning foes to friends: targeting cancer-associated fibroblasts[J].Nat Rev Drug Discov,2019,18(2): 99-115. DOI:10.1038/s41573-018-0004-1. pmid:30470818
[32]	Shi Z, Jiang T, Cao B, et al. CAF-derived exosomes deliver LINC01410 to promote epithelial-mesenchymal transition of esophageal squamous cell carcinoma[J].Exp Cell Res,2022,412(2): 113033. DOI:10.1016/j.yexcr.2022.113033.

Role of linc01410 in the occurrence and development of malignant tumors

RichHTML

PDF

Knowledge

Abstract

Cite this article

share this article

References32

Related Articles15

Recommended Articles

Metrics

Comments

[1]	Liu Na, Kou Jieli, Yang Feng, Liu Taotao, Li Danping, Han Junrui, Yang Lizhou.Clinical value of serum miR-106b-5p and miR-760 combined with low-dose spiral CT in the diagnosis of early lung cancer[J]. Journal of International Oncology, 2024, 51(6): 321-325.
[2]	Yang Mi, Bie Jun, Zhang Jiayong, Deng Jiaxiu, Tang Zuge, Lu Jun.Analysis of the efficacy and prognosis of neoadjuvant therapy for locally advanced resectable esophageal cancer[J]. Journal of International Oncology, 2024, 51(6): 332-337.
[3]	Yuan Jian, Huang Yanhua.Diagnostic value of Hp-IgG antibody combined with serum DKK1 and sB7-H3 in early gastric cancer[J]. Journal of International Oncology, 2024, 51(6): 338-343.
[4]	Chen Hongjian, Zhang Suqing.Study on the relationship between serum miR-24-3p， H2AFX and clinical pathological features and postoperative recurrence in liver cancer patients[J]. Journal of International Oncology, 2024, 51(6): 344-349.
[5]	Guo Zehao, Zhang Junwang.Role of PFDN and its subunits in tumorigenesis and tumor development[J]. Journal of International Oncology, 2024, 51(6): 350-353.
[6]	Zhang Baihong, Yue Hongyun.Advances in anti-tumor drugs with new mechanisms of action[J]. Journal of International Oncology, 2024, 51(6): 354-358.
[7]	Xu Fenglin, Wu Gang.Research progress of EBV in tumor immune microenvironment and immunotherapy of nasopharyngeal carcinoma[J]. Journal of International Oncology, 2024, 51(6): 359-363.
[8]	Wang Ying, Liu Nan, Guo Bing.Advances of antibody-drug conjugate in the therapy of metastatic breast cancer[J]. Journal of International Oncology, 2024, 51(6): 364-369.
[9]	Zhang Rui, Chu Yanliu.Research progress of colorectal cancer risk assessment models based on FIT and gut microbiota[J]. Journal of International Oncology, 2024, 51(6): 370-375.
[10]	Gao Fan, Wang Ping, Du Chao, Chu Yanliu.Research progress on intestinal flora and non-surgical treatment of the colorectal cancer[J]. Journal of International Oncology, 2024, 51(6): 376-381.
[11]	Liu Jing, Liu Qin, Huang Mei.Prognostic model construction of lung infection in patients with chemoradiotherapy for esophageal cancer based on SMOTE algorithm[J]. Journal of International Oncology, 2024, 51(5): 267-273.
[12]	Yang Lin, Lu Ning, Wen Hua, Zhang Mingxin, Zhu Lin.Study on the clinical relationship between inflammatory burden index and gastric cancer[J]. Journal of International Oncology, 2024, 51(5): 274-279.
[13]	Wang Junyi, Hong Kaibin, Ji Rongjia, Chen Dachao.Effect of cancer nodules on liver metastases after radical resection of colorectal cancer[J]. Journal of International Oncology, 2024, 51(5): 280-285.
[14]	Zhang Ningning, Yang Zhe, Tan Limei, Li Zhenning, Wang Di, Wei Yongzhi.Diagnostic value of cervical cell DNA ploidy analysis combined with B7-H4 and PKCδ for cervical cancer[J]. Journal of International Oncology, 2024, 51(5): 286-291.
[15]	Fu Yi, Ma Chenying, Zhang Lu, Zhou Juying.Research progress of habitat analysis in radiomics of malignant tumors[J]. Journal of International Oncology, 2024, 51(5): 292-297.